FDA <\/a>recommend that anyone over the age of 50-years vaccinates against the shingles virus. However, doctors and the CDC also state that people younger than 60-years should not receive the Zostavax version of the vaccine. <\/span><\/p>\n\n\n\nAny patient who experiences a severe or life-threatening reaction of gelatin should also avoid inoculation with Zostavax or Shingrix. Similarly, anyone who has allergies to the antibiotic medicine, neomycin, or any other element of the Shingrix or Zostavax vaccine, should avoid being vaccinated entirely. It\u2019s vital that you inform your doctor of any allergies you have before they innoculate you for shingles.<\/span><\/p>\n\n\n\nAnyone who has a weak immune system, and frequently gets sick, should avoid being vaccinated with either type of shingles product. People with vulnerable immune systems may not be able to build a tolerance to the vaccine, resulting in severe health complications. This principle goes for people living with HIV or AIDS as well. The reduction in active T-cel count means that they may develop health complications after vaccination. <\/span><\/wp-block><\/p>\n\n\n\n\n\n\n\n